Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study for Evaluation of Real-world Efficacy and Safety of T-DM1 in HER2-positive Locally-advanced Unresectable or Metastatic Breast Cancer

NCT04202328 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04202328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04202328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study for Evaluation of Real-world Efficacy and Safety of T-DM1 in HER2-positive Locally-advanced Unresectable or Metastatic Breast Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 19, 2019
Completion date
July 31, 2020
Enrollment
1,000 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer